To identify potential target(s) for therapeutic intervention in a significant proportion of melanomas that harbor dual mut-BRAF and MITF amplification (MITFAmp),14 we developed a multi-step integrative target identification approach—drug-effected integrative identification of target(s) (DEFINIT). This evidence concerns the gene BRAF and melanoma.